Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease. Surface M, Balwani M, Waters C, Haimovich A, et al. Mov Disord 2022 Jan 29. doi: 10.1002/mds.28936.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Surface M, Balwani M, Waters C, Haimovich A, et al. Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease. Mov Disord 2022 Jan 29. doi: 10.1002/mds.28936.
PMID: 35092096